Efficacy of oral pranlukast hydrate, a leukotriene receptor antagonist, in the treatment of postherpetic neuralgia

Akifumi Kanai, Sayano Mori, Satoru Osawa, Asaha Suzuki, Sumio Hoka

研究成果: ジャーナルへの寄稿学術誌査読

2 被引用数 (Scopus)

抄録

The purpose of this study is to investigate the analgesic effect of pranlukast hydrate (PH), a leukotriene receptor antagonist, in patients with postherpetic neuralgia (PHN). Twenty patients with PHN whose pain reached a plateau after 3 or more months received oral administration of PH at doses of 450 mg/day for 1 month. Visual analogue scales of rest pain, tactile allodynia, and paroxysmal pain were significantly reduced at 1 week, 2 weeks, and 1 month after the beginning of oral administration. The analgesic effect was better in patients suffering from PHN for 1 year or more than in the others. This suggests that leukotrienes may play a role in PHN.

本文言語英語
ページ(範囲)389-392
ページ数4
ジャーナルPain Clinic
16
4
DOI
出版ステータス出版済み - 2004
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 臨床神経学
  • 麻酔学および疼痛医療

フィンガープリント

「Efficacy of oral pranlukast hydrate, a leukotriene receptor antagonist, in the treatment of postherpetic neuralgia」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル